Arkolith/Insider Trading/IDYA/Form 4

Ruiz Briseno Andres

Chief Accounting OfficerIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Jul 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$382K
Net Open-Market Flow
-$382K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)10K$12.86$123K36K
Jul 7, 2026Sell(S)10K$40.01$382K26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)10K—$019K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000336) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML